JP2024517760A5 - - Google Patents
Info
- Publication number
- JP2024517760A5 JP2024517760A5 JP2023566750A JP2023566750A JP2024517760A5 JP 2024517760 A5 JP2024517760 A5 JP 2024517760A5 JP 2023566750 A JP2023566750 A JP 2023566750A JP 2023566750 A JP2023566750 A JP 2023566750A JP 2024517760 A5 JP2024517760 A5 JP 2024517760A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- amino acid
- acid sequences
- lcdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163183636P | 2021-05-04 | 2021-05-04 | |
| US63/183,636 | 2021-05-04 | ||
| PCT/IL2022/050451 WO2022234570A1 (en) | 2021-05-04 | 2022-05-02 | Anti-5t4 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517760A JP2024517760A (ja) | 2024-04-23 |
| JP2024517760A5 true JP2024517760A5 (https=) | 2025-04-16 |
Family
ID=83932628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566750A Pending JP2024517760A (ja) | 2021-05-04 | 2022-05-02 | 抗５ｔ４抗体及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240228658A1 (https=) |
| EP (1) | EP4334362A4 (https=) |
| JP (1) | JP2024517760A (https=) |
| KR (1) | KR20240004837A (https=) |
| CN (1) | CN117279951A (https=) |
| AU (1) | AU2022270453A1 (https=) |
| BR (1) | BR112023023086A2 (https=) |
| CA (1) | CA3217716A1 (https=) |
| IL (1) | IL308203A (https=) |
| MX (1) | MX2023013018A (https=) |
| WO (1) | WO2022234570A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024183811A1 (en) * | 2023-03-08 | 2024-09-12 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Anti-5t4 antibodies and uses thereof |
| CN121002067A (zh) * | 2023-04-03 | 2025-11-21 | 非同（成都）生物科技有限公司 | 抗5t4抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012009709A1 (en) * | 2010-07-16 | 2012-01-19 | Sudhir Paul | Hiv cd4 binding site based covalent immunogen compositions |
| WO2015051159A1 (en) * | 2013-10-02 | 2015-04-09 | The Rockefeller University | Amyloid protofibril antibodies and methods of use thereof |
| MX384198B (es) * | 2014-12-19 | 2025-03-14 | Chiome Bioscience Inc | Proteina de fusion que comprende tres dominios de union a 5t4 y cd3. |
| SG11202008399QA (en) * | 2018-03-12 | 2020-09-29 | Genmab As | Antibodies |
| CN116096754A (zh) * | 2020-05-04 | 2023-05-09 | 免疫里森公司 | 前体三特异性抗体构建体及其使用方法 |
-
2022
- 2022-05-02 MX MX2023013018A patent/MX2023013018A/es unknown
- 2022-05-02 IL IL308203A patent/IL308203A/en unknown
- 2022-05-02 CA CA3217716A patent/CA3217716A1/en active Pending
- 2022-05-02 JP JP2023566750A patent/JP2024517760A/ja active Pending
- 2022-05-02 CN CN202280032428.7A patent/CN117279951A/zh active Pending
- 2022-05-02 EP EP22798771.6A patent/EP4334362A4/en active Pending
- 2022-05-02 US US18/558,673 patent/US20240228658A1/en active Pending
- 2022-05-02 BR BR112023023086A patent/BR112023023086A2/pt unknown
- 2022-05-02 KR KR1020237041483A patent/KR20240004837A/ko active Pending
- 2022-05-02 AU AU2022270453A patent/AU2022270453A1/en active Pending
- 2022-05-02 WO PCT/IL2022/050451 patent/WO2022234570A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022191301A5 (https=) | ||
| JP2021521843A5 (https=) | ||
| JP2024020298A5 (https=) | ||
| RU2018145852A (ru) | Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение | |
| JP2021527431A5 (https=) | ||
| RU2018119165A (ru) | Антитело против лиганда 1 запрограммированной гибели клеток (pd-l1), его антигенсвязывающий фрагмент и их медицинское применение | |
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| JP2022533538A5 (https=) | ||
| JP2021524256A5 (https=) | ||
| CN109843927A (zh) | 抗b7-h3抗体、其抗原结合片段及其医药用途 | |
| JP2020522280A5 (https=) | ||
| JP2012532851A5 (https=) | ||
| JP2022509156A5 (https=) | ||
| JP2014524902A5 (https=) | ||
| JP2020522281A5 (https=) | ||
| JP2017512759A5 (https=) | ||
| RU2020127196A (ru) | Антитело против 4-1bb, его антигенсвязывающий фрагмент и его медицинское применение | |
| JP2023093753A5 (https=) | ||
| RU2019139093A (ru) | Фармацевтическая композиция на основе антитела к pd-l1 и ее применение | |
| JP2024540148A5 (https=) | ||
| JP2025501775A5 (https=) | ||
| JP2024517760A5 (https=) | ||
| RU2019135404A (ru) | Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний | |
| JP2022516351A5 (https=) | ||
| JP2021512652A5 (https=) |